Beryl Drugs Promoter Acquires 7500 Shares Open Market

Beryl Drugs Ltd. files SEBI Regulation 29(2) disclosure for promoter Mr. Sudhir Sethi's open market share acquisition.
Sudhir Sethi acquired 7,500 equity shares (0.14%) on 24-March-2026, raising his holding from 9.58% to 9.72%.
Post-acquisition, Sudhir Sethi holds 4,93,983 shares; total equity share capital of Beryl Drugs remains unchanged at 50,71,700 shares.